Alaunos Therapeutics Inc.
TCRT | NASDAQ
$1.26
+$0.06 (+5.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.20
-$0.06 (-4.75%)
Pre-market:
Sep 22, 2026, 4:36 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 5K | 10K | 5K | 2.92M | 398K | n/a |
Cost of Revenue | 1.36M | 362K | 4.8M | 22.52M | 47.28M | 1.13M |
Gross Profit | -1.36M | -352K | -4.8M | -19.6M | -46.88M | -1.13M |
Operating Income | -4.23M | -4.81M | -34.27M | -35.11M | -77.55M | -80.36M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.18M | -4.68M | -35.14M | -37.73M | -78.75M | -79.98M |
Net Income | -4.18M | -4.68M | -35.14M | -37.73M | -78.75M | -79.98M |
Selling & General & Admin | 2.87M | 4.46M | 12.22M | 13.14M | 26.28M | 26.54M |
Research & Development | 1.36M | 362K | 16.28M | 25.02M | 49.64M | 52.7M |
Other Expenses | -1.36M | -362K | 971K | -22.65M | -45.25M | n/a |
Operating Expenses | 2.87M | 4.46M | 29.47M | 15.51M | 30.67M | 79.23M |
Interest Expense | n/a | n/a | 1.92M | 3.15M | 1.19M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.23M | 4.82M | 34.27M | 38.03M | 77.95M | 80.36M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.95M | 1.6M | 1.6M | 1.45M | 1.43M | 1.4M |
Shares Outstanding (Diluted) | 1.95M | 1.6M | 1.6M | 1.45M | 1.43M | 1.4M |
EPS (Basic) | -2.20 | -2.92 | -21.97 | -25.97 | -53.80 | -56.42 |
EPS (Diluted) | -2.20 | -2.92 | -21.97 | -25.97 | -53.80 | -56.42 |
EBITDA | -4.17M | -4.68M | -30.9M | -31.82M | -74.97M | -78.85M |
EBIT | -4.18M | -4.68M | -33.22M | -34.58M | -77.56M | -79.98M |
Depreciation & Amortization | 7K | 2K | 2.32M | 2.76M | 2.6M | 1.13M |
Add to Watchlist
Select watchlists to add or remove TCRT